Coexistence of autosomal dominant polycystic kidney disease and primary hyperoxaluria type 3

Kidney stone is not uncommon in ADPKD but is not associated with #hyperoxaluria.

doi.org/10.1016/j.kint.2025.09.006

#NephSky #MedSky #ADPKD

Lumasiran for PH1 in Infants and Young Children | Docwire News Joel Topf spoke with Mini Michael at NKF SCM25 about the ILLUMINATE-B phase 3 study of lumasiran for primary hyperoxaluria type 1 (PH1) in infants and young children.

Mini Michael discussed lumasiran for treatment of #PH1 in young children, the subject of a late-breaking abstract presented at #NKFClinicals. #nephrology #hyperoxaluria #nephsky @bcmhouston.bsky.social @kidneyboy.bsky.social www.docwirenews.com/post/lumasir...

60-Month Results for Lumasiran in PH1 | Docwire News Research examined the efficacy and safety of lumasiran for primary hyperoxaluria type 1 (PH1) in infants and toddlers.

ILLUMINATE-B examined the efficacy and safety of lumasiran in infants and toddlers with primary hyperoxaluria type 1 (PH1). #kidneydisease #nephsky #nephrology #NKFClinicals #hyperoxaluria
www.docwirenews.com/post/60-mont...

PHYOX3: #Nedosiran Long-Term Safety and Efficacy in Patients With Primary #Hyperoxaluria Type 1

#VisualAbstract by @hellokidneymd.bsky.social

www.kireports.org/ar...

ABO-101 Receives Two FDA Designations for Treating PH1 | Docwire News The FDA has granted orphan drug and rare pediatric disease designations to ABO-101 to treat primary hyperoxaluria type 1 (PH1).

Two FDA designations will help support the development and evaluation of Arbor's ABO-101 to treat primary hyperoxaluria type 1. #hyperoxaluria #nephrology #nephsky #kidney

@purvasharma821 presenting #Hyperoxaluria